Low-mass-ion discriminant equation (LOME) for ovarian cancer screening.
about
Reduced levels of N'-methyl-2-pyridone-5-carboxamide and lysophosphatidylcholine 16:0 in the serum of patients with intrahepatic cholangiocarcinoma, and the correlation with recurrence-free survival.Cerebrospinal fluid metabolomic profiles can discriminate patients with leptomeningeal carcinomatosis from patients at high risk for leptomeningeal metastasis.Profiling of Serum Metabolites Using MALDI-TOF and Triple-TOF Mass Spectrometry to Develop a Screen for Ovarian Cancer.Individualized metabolic profiling stratifies pancreatic and biliary tract cancer: a useful tool for innovative screening programs and predictive strategies in healthcare
P2860
Low-mass-ion discriminant equation (LOME) for ovarian cancer screening.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Low-mass-ion discriminant equation (LOME) for ovarian cancer screening.
@ast
Low-mass-ion discriminant equation (LOME) for ovarian cancer screening.
@en
type
label
Low-mass-ion discriminant equation (LOME) for ovarian cancer screening.
@ast
Low-mass-ion discriminant equation (LOME) for ovarian cancer screening.
@en
prefLabel
Low-mass-ion discriminant equation (LOME) for ovarian cancer screening.
@ast
Low-mass-ion discriminant equation (LOME) for ovarian cancer screening.
@en
P2093
P2860
P1433
P1476
Low-mass-ion discriminant equation (LOME) for ovarian cancer screening.
@en
P2093
Byong Chul Yoo
Jun Hwa Lee
Kyung-Hee Kim
Seung Cheol Kim
Seung-Gu Yeo
Yun Hwan Kim
P2860
P2888
P356
10.1186/S13040-016-0111-7
P50
P577
2016-10-12T00:00:00Z
P6179
1032355670